Published on
Updated on
Researchers at the University of Missouri are developing a new approach to flu vaccines by targeting specific parts of the virus that trigger stronger immune responses. The early-stage model could eventually improve seasonal flu protection and inform future vaccines for other viruses.
Read more at: Columbia MISSOURIAN